United Kingdom pharmaceutical market is expected to register robust growth in the forecast period, 2023-2027. Innovations in the fields of oncology, autoimmune, and diabetes treatment will continue to augment the United Kingdom pharmaceutical market. Emerging markets will see a steady rise is people seeking treatment for these diseases owing to the advancements in treatments and prevention will continue to propel the market growth. Growing number of patients who experience chronic ailments or pain which drives the market growth. In addition to this, chronic illness including hypertension and mental health issues are key driver of the growth in pharmaceutical market in United Kingdom. The pharmaceuticals that treat rare diseases as advancements in pharmaceuticals offer numerous solutions and up-gradations in medicine uncover more problems.

The Expanding Geriatric Population is Projected to Fuel the Market Growth

Chronic conditions are on the rise and patients are often suffering from more than just one ailment. This development is intensified owing to the growing middle-class and escalating adoption of sedentary lifestyles in emerging markets, which results into obesity, diabetes, and other costly health conditions. Chronic noncommunicable disease prevalence such as cardiovascular diseases or cancer are accelerating the demand for pharmaceuticals. The increasing elderly population and the high requirement of more medical care especially to older population are driving the growth of the pharmaceutical market. Government health programs including Medicaid and Medicare enable a wider range of seniors to be covered. Additionally, advancements in healthcare that people are living longer and requiring services for a longer period.

Growing Number of Chronic Diseases is Expected to Bolster the Market Growth

The escalating demand for healthcare and innovative solutions is one of the primary factors propelling the market growth. Digitalization, big data and artificial intelligence drives the transformation of the pharmaceutical sector and allow companies to enhance drug development and patient care beyond the treatment of diseases, which provide a new revenue stream. For patient care, digital solutions allow the shift from a disease focus to an integrated approach from prevention, screening, diagnostic, treatment, and aftercare. Continuous technological advancement and novel therapeutic approaches have the potential to not only treat, but also assist in curing diseases – or identifying and eliminating risk factors before a disease develops. Part of this development are personalized therapies, a promising approach tailoring medical treatment to the individual characteristics of each patient. The emerging associations between the human microbiome, health and disease are leading to novel diagnostics and therapeutics thereby improving personalized medicine.  All these aforementioned factors are expected to augment the pharmaceutical market across United Kingdom during the forecast years.          


DOWNLOAD FREE SAMPLE REPORT                                                                                               

Market Segmentation

The United Kingdom Pharmaceutical market is segmented into drug type, product type, application, distribution channel, regional distribution, and competitive landscape. Based on drug type, the market is bifurcated into generic drugs and branded drugs. Based on product type, the market is divided into prescription drugs and over-the-counter drugs. Based on application, the market is segmented into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, others. Based on end user, the market is divided into retail pharmacy, hospital pharmacy, e-pharmacy. The United Kingdom pharmaceutical market is studied in major regions namely London, Southeast, East Anglia, Scotland, Southwest, East Midlands, Yorkshire & Humberside, Rest of United Kingdom.

Market Players

Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc., Vertex Pharmaceuticals (U.K.) Limited, Pfizer Limited, Novartis UK Limited, AstraZeneca UK Limited, Bristol-Myers Squibb Pharmaceuticals Limited, Roche Products Limited, Sanofi UK, Sun Pharmaceuticals UK Limited are the key market players operating in United Kingdom Pharmaceutical market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Drug Type

·         Product Type

·         Application

·         Distribution Channel

Regional scope

London, Southeast, East Anglia, Scotland, Southwest, East Midlands, Yorkshire & Humberside, Rest of United Kingdom

Key companies profiled

Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc., Vertex Pharmaceuticals (U.K.) Limited, Pfizer Limited, Novartis UK Limited, AstraZeneca UK Limited, Bristol-Myers Squibb Pharmaceuticals Limited, Roche Products Limited, Sanofi UK, Sun Pharmaceuticals UK Limited

Customization scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, United Kingdom Pharmaceutical market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         United Kingdom Pharmaceutical Market, By Drug Type:

o   Generic Drugs

o   Branded Drugs

·         United Kingdom Pharmaceutical Market, By Product Type:

o   Prescription Drugs

o   Over-The-Counter Drugs

·         United Kingdom Pharmaceutical Market, By Application:

o   Cardiovascular

o   Musculoskeletal

o   Oncology

o   Anti-infective

o   Metabolic Disorder

o   Others

·         United Kingdom Pharmaceutical Market, By Distribution Channel:

o   Retail Pharmacy

o   Hospital Pharmacy

o   E-Pharmacy

·         United Kingdom Pharmaceutical Market, By Region:

o   London

o   Southeast

o   East Anglia

o   Scotland

o   Southwest

o   East Midlands

o   Yorkshire & Humberside

o   Rest of United Kingdom

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom Pharmaceutical market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

o   Detailed analysis and profiling of additional market players (up to five).

United Kingdom pharmaceutical market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected] 

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United Kingdom Pharmaceutical Market

4.    Executive Summary

5.    Voice of Customer

6.    United Kingdom Pharmaceutical Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Drug Type (Generic Drugs v/s Branded Drugs)

6.2.2.     By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

6.2.3.     By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

6.2.4.     By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    United Kingdom Generic Drugs Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product Type

7.2.2.     By Application

7.2.3.     By Distribution Channel

8.    United Kingdom Branded Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product Type

8.2.2.     By Application

8.2.3.     By Distribution Channel

9.    Market Dynamics

9.1.     Drivers

9.2.     Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  United Kingdom Economic Profile

13.  Competitive Landscape

13.1.    Takeda Pharmaceutical Company Limited

13.2.    GlaxoSmithKline Plc.

13.3.    Vertex Pharmaceuticals (U.K.) Limited

13.4.    Pfizer Limited

13.5.    Novartis UK Limited

13.6.    AstraZeneca UK Limited

13.7.    Bristol-Myers Squibb Pharmaceuticals Limited

13.8.    Roche Products Limited

13.9.    Sanofi UK

13.10.  Sun Pharmaceuticals UK Limited

14.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]